Halozyme Therapeutics Inc (HALO) stock forecast — our track record

Lyra published 13 HALO stock forecasts beginning on September 16, 2025. Every prediction covered the short term (0 to 3 months), and every one was published before its outcome was known. All outcomes were closed and scored by September 22, 2026. The calls forecast gains ranging from 14% to 24%, with each forecast assessed against the stock's actual performance during its stated window.

Four forecasts reached their targets. Nine received partial credit, and none of them missed. The average success score across all 13 calls was 65.4%. Since every call used the same short-term horizon, the short-term average was also 65.4%. The average peak gain was 17.7%. These results showed that several calls captured upward movement without reaching the full predicted gain, while four achieved the target required for a full score.

The best call was published on June 24, 2026. It predicted 14% growth, and the stock recorded a peak gain of 63.8%. The target was reached in 12 days, and the call received a 100% score. The worst call was published on September 22, 2025. It predicted 20% growth, but the stock's peak gain was 1.1%, so the target was not reached. That call received a 50% score. Overall, the track record combined four full target hits with nine partial results and no misses.